v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (1,021) $ (136)
Reconciliations of net loss to net cash provided by operating activities:    
Depreciation and amortization 1,958 1,852
Non-cash operating lease expense 1,618 1,711
Net investment (accretion) amortization (14) (396)
Deferred Income taxes 23  
Share-based compensation 2,658 2,187
Changes in certain operating assets and liabilities:    
Trade accounts receivable (26,758) (28,961)
Income taxes (570) 260
Prepaid expenses and other (10,804) (70)
Accounts payable 847 (896)
Accrued payroll and related benefits 15,670 16,982
Payroll taxes payable 15,357 5,066
Other accrued liabilities (941) (3,135)
Premium payable 15,923 26,167
Workers' compensation claims liabilities (7,152) (9,835)
Operating lease liabilities (1,607) (1,806)
Other assets and liabilities, net 24 (11)
Net cash provided by operating activities 5,211 8,979
Cash flows from investing activities:    
Purchase of property, equipment and software (4,514) (2,779)
Purchase of investments (5,468)  
Proceeds from sales and maturities of investments 5,685 8,290
Purchase of restricted investments (33,705) (4,649)
Proceeds from sales and maturities of restricted investments 6,024 13,253
Net cash (used in) provided by investing activities (31,978) 14,115
Cash flows from financing activities:    
Repurchases of common stock (9,160) (7,056)
Common stock repurchased on vesting of restricted stock units and performance awards (2,272) (1,456)
Dividends paid (2,059) (1,970)
Proceeds from exercise of stock options and purchase of ESPP shares 693 376
Net cash used in financing activities (12,798) (10,106)
Net (decrease) increase in cash, cash equivalents and restricted cash (39,565) 12,988
Cash, cash equivalents and restricted cash, beginning of period 82,588 74,841
Cash, cash equivalents and restricted cash, end of period $ 43,023 $ 87,829

Source